Write in a clean editor, then format for Cancer Innovation in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cancer Innovation is a peer-reviewed journal published by Wiley, covering Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Ferroptosis and cancer prognosis.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Cancer Innovation 12 (3): 45–58.
Formats any DOI in Cancer Innovation style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Breast Cancer Treatment Studies Ferroptosis and cancer prognosis HER2/EGFR in Cancer Research Diverse Scientific and Economic Studies |
| ISSN | 2770-9183 |
| Citation impact (2-yr) | 3.35 |
| h-index | 18 |
| i10-index | 34 |
| Total citations | 1,360 |
| Open access | Yes |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
With the advances in artificial intelligence (AI), data-driven algorithms are becoming increasingly popular in the medical domain. However, due to the nonlinear and complex behavior of many of these algorithms, decision-making by such algorithms is not trustworthy for clinicians and is considered a black-box process. Hence, the scientific community has introduced explainable artificial intelligence (XAI)…
Breast cancer has replaced lung cancer as the most common malignancy worldwide. The 5-year survival rate of breast cancer has reached 90%. Systemic treatment of breast cancer has developed into a mature system including chemotherapy, targeted therapy, endocrine therapy and immunotherapy. This article summarizes the annual progress of breast cancer chemotherapy, targeted therapy, endocrine therapy…
The 3D cancer models fill the discovery gap of 2D cancer models and play an important role in cancer research. In addition to cancer cells, a range of other factors include the stroma, density and composition of extracellular matrix, cancer-associated immune cells (e.g., cancer-associated fibroblasts cancer cell-stroma interactions and subsequent interactions, and a number of…
Effective treatment of cancer requires understanding the nature of the disease and accurately addressing the main root causes. General risk factors for cancer include poor nutrition, an acidogenic diet, an unhealthy lifestyle, and exposure to carcinogens such as toxins, chemicals, and radiation. The risk of developing cancers may be reduced by sufficient oxygenation and maintaining…
Background: To estimate cardiovascular and cancer death rates by regions and time periods. Design: Novel statistical methods were used to analyze clinical surveillance data. Methods: A multicenter, population-based medical survey was performed. Annual recorded deaths from cardiovascular diseases were analyzed for all 195 countries of the world. It is challenging to model such data; few…
